Figure 7
Validation of the effectiveness of the 11 immune-related lncRNA signature. Kaplan–Meier analysis was performed by stratifying BLCA patients according to risk scores to observe the OS of patients (a). Risk scores and clinical outcomes for each patient (b,c). The ROC curves of this model compared with those of other clinical traits (d). The AUC values of the ROC, including the 1-, 3-, and 5-year OS of BLCA patients (e).
